Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures

被引：3

作者：

Reguiai, Z. ^{[1
,20
]}

Becherel, P. A. ^{[2
]}

Fougerousse, A. C. ^{[3
]}

Chaby, G. ^{[4
]}

Perrot, J. L. ^{[5
]}

Begon, E. ^{[6
]}

Jacobzone-Leveque, C. ^{[7
]}

Boulard, C. ^{[8
]}

Badaoui, A. ^{[9
]}

Poreaux, C. ^{[10
]}

David, L. ^{[11
]}

Quiles-Tsimaratos, N. ^{[11
]}

Lons-Danic, D. ^{[12
]}

Fite, C. ^{[12
]}

Liegeon, A. -l. ^{[13
]}

Patchinsky, A. ^{[13
]}

Parier, J. ^{[14
,15
]}

Garcia, C. ^{[16
]}

Esteve, E. ^{[17
]}

Mohty, R. ^{[18
]}

Mery-Bossard, L. ^{[19
]}

Maccari, F. ^{[3
,15
]}

机构：

[1] Polyclin Courlancy, Dept Dermatol, Reims, France

[2] Antony Hosp, Dermatol & Clin Immunol Unit, Antony, France

[3] Hop Instruct Armees Begin, Dept Dermatol, St Mande, France

[4] CHU Amiens Picardie, Dept Dermatol, Amiens, France

[5] CHU St Etienne, Dept Dermatol, St Etienne, France

[6] Ctr Hosp Rene Dubos, Dept Dermatol, Pontoise, France

[7] Ctr Hosp Bretagne Sud, Dept Dermatol, Lorient, France

[8] Ctr Hosp Le Havre, Dept Dermatol, Le Havre, France

[9] Cabinet Med, Paris, France

[10] Clin Pasteur, Ctr Dermatol Stanislas, Nancy, France

[11] Hop St Joseph, Dept Dermatol, Marseille, France

[12] Hop Paris St Joseph, Dept Dermatol, Paris, France

[13] Ctr Hosp Reg Metz Thionville, Dept Dermatol, Thionville, France

[14] Hop St Louis, Ctr Sante Sabouraud, Paris, France

[15] Cabinet Med, St Maur Des Fosses, France

[16] Ctr Hosp Emile Roux, Dept Dermatol, Le Puy En Velay, France

[17] Ctr Hosp Orleans, Dept Dermatol, Orleans, France

[18] Cabinet Med, Beauvais, France

[19] CHI Poissy St Germain, Dept Dermatol, St Germain En Laye, France

[20] Polyclin Courlancy Bezannes, Dept Dermatol, 89 Rue Louis Victor Broglie, F-51430 Bezannes, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 11期

关键词：

D O I：

10.1111/jdv.19302

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E1307 / E1309

页数：3

共 50 条

[1] Efficacy of Janus kinase inhibitors in the treatment of psoriasiform atopic dermatitis
Napolitano, Maddalena
Foggia, Luciano
Patruno, Cataldo
Gallo, Lucia
Tommasino, Nello
Cecere, Daniele
Megna, Matteo
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1232 - 1234
[2] Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
Le, Michelle
Berman-Rosa, Melissa
Ghazawi, Feras M.
Bourcier, Marc
Fiorillo, Loretta
Gooderham, Melinda
Guenther, Lyn
Hanna, Sameh
Hong, H. Chih-Ho
Landells, Ian
Lansang, Perla
Marcoux, Danielle
Wiseman, Marni C.
Yeung, Jensen
Lynde, Charles
Litvinov, Ivan V.
FRONTIERS IN MEDICINE, 2021, 8
[3] THE IMPACT OF PHARMACOVIGILANCE RISK ASSESSMENT COMMITTEE (PRAC) RECOMMENDATIONS ON THE REAL-LIFE USE OF JANUS KINASES INHIBITORS FOR RHEUMATOID ARTHRITIS
Favalli, E. G.
Ferrito, M.
Di Taranto, R.
Biggioggero, M.
Orsini, F.
Germinario, S.
Cincinelli, G.
Caporali, R.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1423 - 1424
[4] EFFECTIVENESS AND TOLERANCE OF JANUS KINASE INHIBITORS FOR THE TREATMENT OF RECALCITRANT ATOPIC DERMATITIS IN A REAL-LIFE FRENCH MULTICENTER ADULT COHORT
Vanlerberghe, Julia
Dezoteux, Frederic
Martin, Claire
Jachiet, Marie
Soria, Angele
Tetart, Florence
Modeste-Duval, Anne-Benedicte
Bursztejn, Anne-Claire
Misery, Laurent
Aubin, Francois
Lasek, Audrey
Leleu, Camille
Du-Thanh, Aurelie
Pasteur, Justine
Pralong, Pauline
Nosbaum, Audrey
Droitcourt, Catherine
Viguier, Manuelle
Tauber, Marie
Seneschal, Julien
Barbarot, Sebastien
Staumont-Salle, Delphine
ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 28 - 28
[5] Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort
Vanlerberghe, Julia
Dezoteux, Frederic
Martin, Claire
Jachiet, Marie
Soria, Angele
Tetart, Florence
Modeste-Duval, Anne-Benedicte
Bursztejn, Anne-Claire
Misery, Laurent
Aubin, Francois
Lasek, Audrey
Leleu, Camille
Du-Thanh, Aurelie
Pasteur, Justine
Pralong, Pauline
Nosbaum, Audrey
Droitcourt, Catherine
Viguier, Manuelle
Tauber, Marie
Seneschal, Julien
Barbarot, Sebastien
Staumont-Salle, Delphine
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (04) : 900 - 904
[6] Effectiveness of Janus Kinase Inhibitors for the Management of Atopic Dermatitis and Concomitant Occupational Allergic Contact Dermatitis: A Real-Life Study
Potestio, Luca
Patruno, Cataldo
Feo, Federica
Coronella, Luigi
di Vico, Francesca
Napolitano, Maddalena
DERMATITIS, 2025,
[7] Efficacy and Risk Stratification of Janus Kinase Inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis
Narla, Shanthi
Silverberg, Jonathan I.
DERMATITIS, 2024, 35 : S24 - S38
[8] Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
Li, Chenyang
Sun, Xun
Zhao, Kun
Meng, Fanxiang
Li, Lin
Mu, Zhenzhen
Han, Xiuping
DERMATOLOGY, 2022, 238 (04) : 725 - 735
[9] Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis
Wang, Mingyue
Gao, Xinghua
Zhang, Li
ALLERGY AND ASTHMA PROCEEDINGS, 2025, 46 (02) : 88 - 97
[10] Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis
Wood, Hannah
Chandler, Antoinette
Nezamololama, Novin
Papp, Kim
Gooderham, Melinda J.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : 746 - 754

← 1 2 3 4 5 →